Researchers have identified a new genetic eye disease that affects the macula.
The AREDS2 dietary supplement that substitutes antioxidants lutein and zeaxanthin for beta-carotene reduces the risk of age-related macular degeneration progression, a new study reveals.
Children diagnosed with ASD at 24 months had differences in visual processing areas of the brain which were apparent at six months of age, a new study reports.
Study reports a significant decline in smoking for those with major depression and substance use disorders, signifying smoking cessation treatments and campaigns are effective in targeting those in groups considered high risk for developing nicotine addiction.
While microsaccades appear to boost or diminish the strength of brain signals associated with attention, eye movements are not drivers for these brain signals.
An analysis of user posts from the Reddit r/selfharm forum found people who self-harm describe their activities as an "addiction", marked with characteristic cravings and an escalation in severity or tolerance.
3,6’-dithiopomalidomide (DP), an anti-inflammatory drug candidate, protected mouse models of Alzheimer's disease against cognitive decline by reducing neuroinflammation.
Mislocalization of the TDP-43 protein alters the genetic instructions for UNC13A. The findings provide a potential new therapeutic target for the treatment of ALS and frontotemporal dementia.
Dasatinib, an FDA-approved drug for chronic myeloid leukemia, and an experimental drug for liver cancer reduced neuroinflammation, tau phosphorylation, and amyloid secretion in cell cultures of post-mortem brain samples of those with the APOE4 Alzheimer's associated gene.
A new rodent study uncovers a neural circuit in the brain that appears to govern pain-induced anhedonia. Altering the activity of this circuit restored motivation in pre-clinical models of pain.
Study finds a link between post-traumatic brain activity and an increase in anxiety symptoms six months after a traumatic event.
Bumetanide, an FDA-approved potent diuretic used to treat fluid retention caused by heart, kidney, and liver disease may lower the risk of developing Alzheimer's disease for those with a genetic predisposition.
